Senate Proposal To Allow Generic Versions Of Biotech Drugs After 12 Years

Senate Proposal To Allow Generic Versions Of Biotech Drugs After 12 Years

A Senate proposal would strip biotech drugs of their patent-protected status after twelve years, opening the door to competition from generic drug makers. Patent protection determines how long obnoxious pharmaceutical CEOs can spend outside their competitor’s offices dancing with their drugs to MC Hammer’s 1990 hit, “U Can’t Touch This.” Unlike regular drugs made by chemical synthesis, biotech drugs are derived from human proteins.